lawsuits against semaglutide Novo Nordisk expands weight-loss drug compounders Ozempic, Mounjaro cause gastrointestinal issues,

Keep the bottle tightly closed when not in use to maintain the potency of the ingredients

Next step: To explore PHGG and other gut-supportive fibres, visit our Gut Health & Fibre collection or discuss suitable options and dosing with your healthcare practitioner

PT-141 is available as a nasal spray or subcutaneous injection

In December 2020, the FDA also approved liraglutide for treatment of obesity in adolescents 1217 years of age

After 46 weeks of treatment: 0.6 mg dose: 6.2% mean body weight reduction 2.4 mg dose: 12.5% mean body weight reduction 3.6 mg dose: 13.2% mean body weight reduction 4.8 mg dose: 14.9% mean body weight reduction (all randomized) 4.8 mg dose: 18.7% mean body weight reduction (completers only) Placebo: 2.8% mean body weight reduction Among completers at the 4.8 mg dose, 68.8% achieved at least 10% weight loss, 67% achieved at least 15%, and 40% achieved at least 20% weight loss